| Colon Cancer Cohort | Rectal Cancer Cohort | Overall CRC Cohort | Comparison Cohort | ||||
---|---|---|---|---|---|---|---|---|
N | 52,371 | Â | 18,619 | Â | 70,990 | Â | 70,990 | Â |
Age (mean (± SD)* | 77.5 | (6.90) | 76.5 | (6.80) | 77.3 | (6.90) | 77.3 | (6.90) |
Male* | 42.8% | Â | 50.5% | Â | 44.9% | Â | 44.9% | Â |
Race/ethnicity | Â | Â | Â | Â | Â | Â | Â | Â |
   White, non-Hispanic | 86.2% |  | 86.9% |  | 86.4% |  | 86.8% |  |
   African American, non-Hispanic | 7.8% |  | 6.1% |  | 7.3% |  | 6.5% |  |
   Hispanic, any race | 1.1% |  | 1.2% |  | 1.1% |  | 1.9% |  |
   Other | 5.0% |  | 5.7% |  | 5.2% |  | 4.8% |  |
Geographic region* | Â | Â | Â | Â | Â | Â | Â | Â |
   Northeast | 19.3% |  | 19.6% |  | 19.4% |  | 19.4% |  |
   Midwest | 27.3% |  | 27.6% |  | 27.4% |  | 27.4% |  |
   West | 42.0% |  | 42.4% |  | 42.1% |  | 42.1% |  |
   South | 11.3% |  | 10.4% |  | 11.1% |  | 11.1% |  |
Charlson score (mean (± SD)1 | 0.5 | (1.00) | 0.4 | (0.90) | 0.5 | (1.00) | 0.4 | (0.90) |
Selected Charlson comorbidities | Â | Â | Â | Â | Â | Â | Â | Â |
   Chronic pulmonary/respiratory disease | 8.9% |  | 7.9% |  | 8.6% |  | 7.1% |  |
   Congestive heart failure | 7.9% |  | 6.0% |  | 7.4% |  | 5.9% |  |
   Diabetes without complications | 10.1% |  | 8.4% |  | 9.6% |  | 7.6% |  |
   Cerebrovascular disease | 6.0% |  | 4.8% |  | 5.7% |  | 5.7% |  |
   Myocardial infarction | 3.2% |  | 2.5% |  | 3.0% |  | 2.6% |  |
   Peptic ulcer | 2.4% |  | 1.5% |  | 2.2% |  | 1.2% |  |
   Other major conditions2 | 7.2% |  | 7.2% |  | 7.2% |  | 7.3% |  |
Stage at diagnosis (%) | Â | Â | Â | Â | Â | Â | Â | Â |
   Stage I | 23.7% |  | 32.4% |  | 26.0% |  | ** |  |
   Stage II | 34.6% |  | 25.1% |  | 32.1% |  | ** |  |
   Stage III | 24.6% |  | 22.2% |  | 23.9% |  | ** |  |
   Stage IV | 17.2% |  | 20.2% |  | 18.0% |  | ** |  |